Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

CCBR Clinical Research (Now Bioclinica)CCBR Clinical Research (Now Bioclinica)
VS
MANKIND PHARMA LTDMANKIND PHARMA LTD
CCBR Clinical Research (Now Bioclinica)

CCBR Clinical Research (Now Bioclinica)

N/A

Last Update: 01/01/2026

View Profile

CCBR is now Bioclinica. Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologi...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:104
Subsidiaries:4
12-month incidents
0
Known data breaches
0
Attack type number
0
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Phase 3, New Delhi, IN

Last Update: 04/04/2026

View Profile
Between 750 and 799
http://www.mankindpharma.com
779/1000Fair

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:17,740
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
CCBR Clinical Research (Now Bioclinica)

CCBR Clinical Research (Now Bioclinica)

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MANKIND PHARMA LTD

MANKIND PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for CCBR Clinical Research (Now Bioclinica) in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MANKIND PHARMA LTD in 2026.

Incidents

Incident History - CCBR Clinical Research (Now Bioclinica) (X = Date, Y = Severity)

CCBR Clinical Research (Now Bioclinica) cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MANKIND PHARMA LTD (X = Date, Y = Severity)

MANKIND PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
CCBR Clinical Research (Now Bioclinica)

CCBR Clinical Research (Now Bioclinica)

Incidents
No explicit notable incidents reported.
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Incidents
No explicit notable incidents reported.

FAQ

Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one has the best AI Cybersecurity Score ?
Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents in the past ?
Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents this year ?
Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one has experienced at least one ransomware attack ?
Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one has experienced at least one data breach ?
Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one has experienced at least one targeted cyberattack ?
Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one has experienced at least one vulnerability ?
Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one holds the most compliance certifications ?
Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one holds the fewest compliance certifications ?
Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one has the most subsidiaries ?
Between CCBR Clinical Research (Now Bioclinica) company and MANKIND PHARMA LTD company, which one has the largest number of employees ?
Between CCBR Clinical Research (Now Bioclinica) and MANKIND PHARMA LTD, which company holds both SOC 2 Type 1 certifications ?
Between CCBR Clinical Research (Now Bioclinica) and MANKIND PHARMA LTD, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - CCBR Clinical Research (Now Bioclinica) or MANKIND PHARMA LTD ?
Which company is PCI DSS compliant - CCBR Clinical Research (Now Bioclinica) or MANKIND PHARMA LTD ?
Between CCBR Clinical Research (Now Bioclinica) and MANKIND PHARMA LTD, which company complies with HIPAA regulations for healthcare data ?
Between CCBR Clinical Research (Now Bioclinica) and MANKIND PHARMA LTD, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-45537
SUMMARY

OpenSIPS is a Session Initiation Protocol (SIP) server implementation. In versions prior to 3.6.6 and 4.0.0-rc1, the construct_uri() function concatenates multiple URI components (protocol, username, domain, port, params) into a fixed 1024-byte global BSS buffer without any bounds checking. When a routing script calls construct_uri() with an attacker-controlled username, a combined component length exceeding 1024 bytes overflows the buffer, corrupting adjacent global data with attacker-controlled content. The overflow reaches disable_503_translation, a global flag controlling SIP 503 response handling, allowing an attacker to deterministically set the flag via the URI username and alter the server's routing behavior for subsequent messages. Because the same buffer is shared with contact_builder(), the overflow also corrupts that function's data, and without a memory sanitizer the adjacent globals are silently overwritten on every request containing a long username. This issue has been fixed in versions 3.6.6 and 4.0.0-rc1.

PUBLISHED
Date2026-08-04
UPDATED
Date2026-08-04
RISK INFORMATION (Score: 9.1)
CVSS3
Base Score: 9.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:H
IMPACT SCORE
5.2
EXPLOITABILITY
3.9
CVE-2026-18819
SUMMARY

A security vulnerability has been detected in RackTables up to 0.22.0/e5fff9f8aab339798ed47e8c6d7d977ed97a82bd. This vulnerability affects unknown code. The manipulation leads to cross-site request forgery. The attack is possible to be carried out remotely. The exploit has been disclosed publicly and may be used. The project maintainer confirms: "[I]t seems plausible, in that RackTables does not at this time have any CSRF prevention. You may assign a CVE ID to this, but there is no guarantee it will be handled in urgent, or even timely, manner, or at all."

PUBLISHED
Date2026-08-04
UPDATED
Date2026-08-04
RISK INFORMATION (Score: 4.3)
CVSS2
Base Score: 5.0
Complexity: LOW
AV:N/AC:L/Au:N/C:N/I:P/A:N
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-18818
SUMMARY

A weakness has been identified in Ehco1996 django-sspanel up to 2023.12.26. This affects the function TicketDetailView of the file apps/sspanel/views.py of the component Support Ticket Handler. Executing a manipulation can lead to authorization bypass. The attack can be executed remotely. The vendor was contacted early about this disclosure but did not respond in any way. This vulnerability only affects products that are no longer supported by the maintainer.

PUBLISHED
Date2026-08-04
UPDATED
Date2026-08-04
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-70620
SUMMARY

Odysseus before commit 87babb5 contains a server-side request forgery vulnerability that allows admin-privileged attackers to direct the server to probe internal network resources by supplying arbitrary URLs to the embedding endpoint configuration without scheme, host, IP range, or DNS rebind validation. Attackers can submit loopback addresses, RFC 1918 ranges, or link-local addresses through the embedding endpoint API to partially read responses from cloud instance metadata services, internal APIs, and other hosts reachable from the server.

PUBLISHED
Date2026-08-04
UPDATED
Date2026-08-04
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:N/A:N
CVSS4
Base Score: 6.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4
EXPLOITABILITY
2.3
CVE-2026-70619
SUMMARY

Odysseus before commit bf325f6 contains a missing authorization vulnerability that allows authenticated non-admin users to manage server-wide embedding backend configuration by invoking endpoint management routes that verify session authentication but omit the admin authorization guard. Attackers can supply an attacker-controlled URL to overwrite the embedding backend persisted in the endpoint configuration file and process environment, causing all subsequent embedding operations including chat messages, RAG queries, memory entries, and vault text to be transmitted in plaintext to the attacker-controlled destination, or delete the endpoint configuration to deny embedding service to all users.

PUBLISHED
Date2026-08-04
UPDATED
Date2026-08-04
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8